🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Trial investigates the benefits and harms of Levodopa /Carbidopa 100/25mg c...
Status
Active Not Recruiting
Location
Kantonsspital Aarau, Neurozentrum
Start Date
2019-06-14
Trial ID
NCT03735901
Treatments Being Tested
Researchers conducting this study hope to learn about the safety and effect...
Status
Recruiting
Location
University of Chicago Comprehensive Cancer Center
Start Date
2025-01-06
Trial ID
NCT05726292
This trial is divided into two parts, a dose-escalation study (phase 1) and...
Status
Suspended
Location
University of Alabama at Birmingham
Start Date
2013-08
Trial ID
NCT01933815
Treatments Being Tested
This trial is part of the Horizon 2020 project, REPO-TRIAL, on in-silico, m...
Status
Completed
Location
UniversitätsKlinikum Heidelberg - Medizinische Klinik
Start Date
2021-03-18
Trial ID
NCT04776499
Treatments Being Tested
The purpose of this study is: * To assess the effect of BIA 5 1058 400 mg ...
Status
Completed
Location
Simbec Research Ltd (Simbec)
Start Date
2018-06-11
Trial ID
NCT07173738
Treatments Being Tested
Clinical Trial to Evaluate the Efficacy and Safety of CKD-342...
Status
Completed
Location
Samsung Medical Center
Start Date
2015-05
Trial ID
NCT02498509
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, single-a...
Status
Completed
Location
Parexel International
Start Date
2024-07-11
Trial ID
NCT06562114
Treatments Being Tested
Randomized, placebo-controlled trial with a 2x2 factorial design testing th...
Status
Completed
Location
Children's Hospital of Philadelphia
Start Date
2020-09-03
Trial ID
NCT04192136
Treatments Being Tested
This is a randomized, double-blind, placebo-parallel intervention clinical ...
Status
Unknown
Location
The Second Affiliated Hospital of Chongqing Medical University
Start Date
2022-05-01
Trial ID
NCT06127498
This is a Phase 1/2 study of the combination of Ad-p53 administered intra-a...
Status
Terminated
Location
MD Anderson Cancer Center
Start Date
2018-11-20
Trial ID
NCT02842125